In contrast, human chronic cholestatic liver diseases such as PBC are associated with minor elevations of ALT, as exemplified in a recent clinical trial cohort of PBC patients with insufficiently controlled disease, where mean baseline ALT was only marginally elevated (56 U/L) [37]. The gene discussed is GPT; the disease is primary biliary cholangitis.